Natriumklorid B. Braun 9 mg/ml infusjonsvæske

DRUG3 trials

Sponsors

St. Olavs Hospital HF, Norwegian University Of Science And Technolology, Oslo University Hospital HF

Conditions

Acute ischemic strokeChronic cluster headacheChronic migraine

Phase 2

A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusion weighted imaging on MRI after treatment with intravenous tocilizumab or placebo in patients above 18 years of age with acute ischemic stroke undergoing endovascular thrombectomy.

Not yet recruitingCTIS2025-521269-28-00

Oslo University Hospital HFAcute ischemic stroke

Target: 156Updated: 2026-03-12

Phase 3

MiBlock - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic migraine

CompletedCTIS2024-515165-34-00

St. Olavs Hospital HFChronic migraine

Start: 2019-10-01End: 2025-06-13Target: 170Updated: 2024-07-12

BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headache

RecruitingCTIS2024-515166-14-00

Norwegian University Of Science And TechnolologyChronic cluster headache

Start: 2019-11-01Target: 49Updated: 2025-05-26